Anika Therapeutics, Inc. (ANIK) Reports Q3 EPS of 22c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/27/2026
- Wall St rises as AI momentum holds heading into key earnings, Fed decision
- Meta's $97.5B AI money grab: why Zuckerberg is racing to raise cash before rivals
- Deutsche Bank’s Reid sees potential final dip this year before Santa rally
- UPS tops estimates as efficiency drive gains momentum
- GM to move stock listing to Nasdaq in November, shares gain
Tweet
Share
E-mailGet Alerts ANIK Hot Sheet
Price: $21.29 +0.09%
EPS Growth %: +950.0%
Financial Fact:
Net income: 0.61
Today's EPS Names:
OMID, SICP, SCKT, More
EPS Growth %: +950.0%
Financial Fact:
Net income: 0.61
Today's EPS Names:
OMID, SICP, SCKT, More
Join SI Premium – FREE
Anika Therapeutics, Inc. (NASDAQ: ANIK) reported Q3 EPS of $0.22, vs. the analyst estimate of $0.11. Revenue for the quarter came in at $18.5 million versus the consensus estimate of $15.1 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- CTS Corp. (CTS) Tops Q3 EPS by 10c ; Offers Guidance
- Repligen (RGEN) Tops Q3 EPS by 7c ; Offers Guidance
- Herc Holdings (HRI) Tops Q3 EPS by 95c ; Offers Guidance
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
